[go: up one dir, main page]

IL153864A0 - Cyclic polyamine compounds and methods for the preparation thereof - Google Patents

Cyclic polyamine compounds and methods for the preparation thereof

Info

Publication number
IL153864A0
IL153864A0 IL15386401A IL15386401A IL153864A0 IL 153864 A0 IL153864 A0 IL 153864A0 IL 15386401 A IL15386401 A IL 15386401A IL 15386401 A IL15386401 A IL 15386401A IL 153864 A0 IL153864 A0 IL 153864A0
Authority
IL
Israel
Prior art keywords
preparation
methods
polyamine compounds
cyclic polyamine
cyclic
Prior art date
Application number
IL15386401A
Other languages
English (en)
Original Assignee
Slil Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slil Biomedical Corp filed Critical Slil Biomedical Corp
Publication of IL153864A0 publication Critical patent/IL153864A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15386401A 2000-08-02 2001-08-02 Cyclic polyamine compounds and methods for the preparation thereof IL153864A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22252200P 2000-08-02 2000-08-02
PCT/US2001/024282 WO2002010142A1 (fr) 2000-08-02 2001-08-02 Composes de polyamine cyclique pour la cancerotherapie

Publications (1)

Publication Number Publication Date
IL153864A0 true IL153864A0 (en) 2003-07-31

Family

ID=22832553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15386401A IL153864A0 (en) 2000-08-02 2001-08-02 Cyclic polyamine compounds and methods for the preparation thereof

Country Status (7)

Country Link
EP (1) EP1305299A1 (fr)
JP (1) JP2004505112A (fr)
AU (2) AU7814301A (fr)
CA (1) CA2417064A1 (fr)
IL (1) IL153864A0 (fr)
MX (1) MXPA03000905A (fr)
WO (1) WO2002010142A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE335719T1 (de) 1999-04-30 2006-09-15 Cellgate Inc Polyamine und ihre therapeutische verwendung
WO2002091989A2 (fr) 2000-11-08 2002-11-21 Slil Biomedical Corporation Therapies antivirales a base de conjugues d'acides amines a une polyamine ou a des analogues de polyamine
AU2003279756A1 (en) * 2002-06-26 2004-01-19 Cellgate, Inc. Porphyrin-polyamine conjugates for cancer therapy
EP1940773B1 (fr) 2005-08-10 2015-03-18 Johns Hopkins University Polyamines utiles en tant q'agents therapeutiques antiparasites et anticancereux et en tant qu'inhibiteurs de demethylase specifiques a la lysine
US9241898B2 (en) 2008-03-11 2016-01-26 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US10465042B2 (en) 2011-12-02 2019-11-05 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
WO2013082529A1 (fr) 2011-12-02 2013-06-06 Yale University Synthèse enzymatique de poly(amine-co-esters) et ses méthodes d'utilisation pour une libération de gènes
US9895451B2 (en) 2011-12-02 2018-02-20 Yale University Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
ES2899730T3 (es) 2012-03-07 2022-03-14 Mclean Hospital Corp Derivados de la aminoquinolina y sus usos
WO2013173203A1 (fr) * 2012-05-15 2013-11-21 Thermo Electron Scientific Instruments Llc Revêtement de séparateur de faisceau diélectrique multicouche à ultra large bande
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
EP3721875B1 (fr) 2014-05-09 2023-11-08 Yale University Particules revêtues de polyglycérol hyperramifié et leurs procédés de fabrication
CN106852146B (zh) 2014-05-21 2021-08-13 恩特拉达治疗学股份有限公司 细胞穿透肽及其制备和使用方法
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
WO2016033368A1 (fr) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Inhibiteurs améliorés de la peptidyl-calcineurine
US10682422B2 (en) 2014-11-18 2020-06-16 Yale University Formulations for targeted release of agents under low pH conditions and methods of use thereof
WO2016081621A1 (fr) 2014-11-18 2016-05-26 Yale University Formulations à libération ciblée d'agents sous des conditions de ph bas, et procédés d'utilisation de celles-ci
CA3014795A1 (fr) 2016-02-16 2017-08-24 Yale University Compositions et procedes pour le traitement de la mucoviscidose
CA3014792A1 (fr) 2016-02-16 2017-08-24 Carnegie Mellon University Compositions permettant d'ameliorer l'edition ciblee de genes et leurs procedes d'utilisation
WO2017197128A1 (fr) 2016-05-11 2017-11-16 Yale University Nanoparticules de poly(amine-co-ester) et leurs procédés d'utilisation
WO2018187493A1 (fr) 2017-04-04 2018-10-11 Yale University Compositions et procédés d'administration in utero
EP3749365A4 (fr) 2018-01-29 2022-01-12 Ohio State Innovation Foundation Inhibiteurs peptidyliques de l'interaction calcineurine-nfat
TW201945014A (zh) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 用於治療粒線體性神經胃腸腦病變之組合物及方法
WO2019217682A1 (fr) 2018-05-09 2019-11-14 Ohio State Innovation Foundation Peptides cycliques de pénétration cellulaire avec un ou plusieurs résidus hydrophobes
WO2020033951A1 (fr) 2018-08-10 2020-02-13 Yale University Compositions et procédés d'édition de gène embryonnaire in vitro
US11814464B2 (en) 2019-04-29 2023-11-14 Yale University Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
WO2020257776A1 (fr) 2019-06-21 2020-12-24 Yale University Compositions d'acides nucléiques peptidiques ayant des segments de liaison de type hoogsteen modifiés et leurs procédés d'utilisation
WO2020257779A1 (fr) 2019-06-21 2020-12-24 Yale University Compositions pna à gamma-hydroxyméthyle modifiée et leurs procédés d'utilisation
US20220280656A1 (en) 2019-07-31 2022-09-08 Yale University Compositions and methods for treating sickle cell disease
CA3183351A1 (fr) 2020-06-19 2021-12-23 Yale University Polymeres de poly(amine-co-ester) presentant des groupes terminaux modifies et administration pulmonaire amelioree
US20220031633A1 (en) 2020-07-28 2022-02-03 Yale University Poly(amine-co-ester) polymeric particles for selective pulmonary delivery
JP2025502630A (ja) 2021-12-08 2025-01-28 イエール・ユニバーシテイ ナノ粒子免疫原性組成物及びワクチン接種法
WO2023159189A1 (fr) 2022-02-18 2023-08-24 Yale University Polymères de poly(amine-co-ester) ramifiés pour une expression nucléique plus efficace
GB202307563D0 (en) 2023-05-19 2023-07-05 Univ King Abdullah Sci & Tech Methods and compositions
WO2025024693A1 (fr) 2023-07-25 2025-01-30 Massachusetts Institute Of Technology Compositions et procédés de traitement de troubles d'expansion de répétition trinucléotidique associés à fan1
CN117088825A (zh) * 2023-10-12 2023-11-21 成都威斯津生物医药科技有限公司 一种可离子化脂质、含该可离子化脂质的药物组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999349A (en) * 1990-03-22 1991-03-12 Bristol-Myers Squibb Co. BU-4164E - A and B, prolyl endopeptidase inhibitors
DE69704731D1 (de) * 1996-02-27 2001-06-13 Lilly Co Eli Cryptophycinderivate und ihre Verwendung als antimikrotubuli Mittel

Also Published As

Publication number Publication date
JP2004505112A (ja) 2004-02-19
EP1305299A1 (fr) 2003-05-02
MXPA03000905A (es) 2003-06-24
WO2002010142A1 (fr) 2002-02-07
AU2001278143B2 (en) 2007-08-09
CA2417064A1 (fr) 2002-02-07
AU7814301A (en) 2002-02-13

Similar Documents

Publication Publication Date Title
IL153864A0 (en) Cyclic polyamine compounds and methods for the preparation thereof
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
IL150908A0 (en) Single phase gels and methods for the preparation thereof
AU6275601A (en) Stable polymeric micelle-type drug composition and method for the preparation thereof
AU4114201A (en) Cyclic compounds
GB0008264D0 (en) Novel method and compounds
HUP0402067A3 (en) Vaccines
EP1313477A4 (fr) Composes et procedes
AU1591402A (en) Vaccine
GB0024200D0 (en) Component vaccine
IL155177A0 (en) Method for the preparation of grf-peg conjugate
EP1434772A4 (fr) Composes et procedes
IL153505A0 (en) Dds compound and process for the preparation thereof
GB0015923D0 (en) Methods
TW426082U (en) Locking device
EP1343796A4 (fr) Composes et procedes
GB0026094D0 (en) Methods
EP1379240A4 (fr) Composes et methodes
GB0031390D0 (en) Methods
GB0003082D0 (en) Vaccine
GB0027433D0 (en) Vaccine component
GB0102454D0 (en) Methods
GB0021859D0 (en) Methods
GB0004533D0 (en) Vaccines
EP1338275A4 (fr) Composition pharmaceutique, son application et procede de fabrication